BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 14733596)

  • 1. Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system.
    Türk H; Haag R; Alban S
    Bioconjug Chem; 2004; 15(1):162-7. PubMed ID: 14733596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
    Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
    Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated Dendritic Polyglycerol Is a Potent Complement Inhibitor.
    Silberreis K; Niesler N; Rades N; Haag R; Dernedde J
    Biomacromolecules; 2019 Oct; 20(10):3809-3818. PubMed ID: 31461260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticomplement function of heparin].
    Huang SW
    Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):360-3. PubMed ID: 6544523
    [No Abstract]   [Full Text] [Related]  

  • 7. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between the complement modulating effects of an arabinogalactan-protein from Echinacea purpurea and heparin.
    Alban S; Classen B; Brunner G; Blaschek W
    Planta Med; 2002 Dec; 68(12):1118-24. PubMed ID: 12494341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of dendritic polyglycerol anions and their efficiency toward L-selectin inhibition.
    Weinhart M; Gröger D; Enders S; Dernedde J; Haag R
    Biomacromolecules; 2011 Jul; 12(7):2502-11. PubMed ID: 21598905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE; Khan SI; Poojari KA
    Bioorg Med Chem; 2005 Aug; 13(16):4891-9. PubMed ID: 15978815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
    Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
    Martinichen-Herrero JC; Carbonero ER; Sassaki GL; Gorin PA; Iacomini M
    Int J Biol Macromol; 2005 Mar; 35(1-2):97-102. PubMed ID: 15769521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
    Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
    Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of polyglycerol sulfate branching on inflammatory processes.
    Paulus F; Schulze R; Steinhilber D; Zieringer M; Steinke I; Welker P; Licha K; Wedepohl S; Dernedde J; Haag R
    Macromol Biosci; 2014 May; 14(5):643-54. PubMed ID: 24446246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of equine complement activity by polysulfated glycosaminoglycans.
    Rashmir-Raven AM; Coyne CP; Fenwick BW; Gaughan EM; Andrews GA; DeBowes RM
    Am J Vet Res; 1992 Jan; 53(1):87-90. PubMed ID: 1539920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement modulating and anticoagulant effects of a sulfated exopolysaccharide released by the cyanobacterium Synechocystis aquatilis.
    Volk RB; Venzke K; Blaschek W; Alban S
    Planta Med; 2006 Dec; 72(15):1424-7. PubMed ID: 17051462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant Heparin Mimetics via RAFT Polymerization.
    Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
    Biomacromolecules; 2020 Feb; 21(2):1009-1021. PubMed ID: 31841320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement activation in heparin--plasma inhibitory effect of anticoagulants on serum complement activation, 2nd report].
    Kobayashi E; Kitano E; Kondo H; Kitamura H
    Rinsho Byori; 2000 Jan; 48(1):60-6. PubMed ID: 10756677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.